XML 47 R32.htm IDEA: XBRL DOCUMENT v3.20.1
FAIR VALUE (Tables)
3 Months Ended
Mar. 31, 2020
Fair Value Disclosures [Abstract]  
Fair Value, by Balance Sheet Grouping
The short-term nature of cash and cash-equivalents, receivables and accounts payable causes each of their carrying values to approximate fair value. The fair value of short-term investments included in cash and cash-equivalents is a Level I valuation. The Company’s other financial assets and financial liabilities by fair-value hierarchy level are set forth below. Please see notes 10 and 18 for the fair value of the Company’s outstanding debt obligations and amounts due from/to affiliates, respectively.

As of March 31, 2020As of December 31, 2019
Level ILevel IILevel IIITotalLevel ILevel IILevel IIITotal
Assets
U.S. Treasury and other securities (1)
$8,611  $—  $—  $8,611  $9,232  $—  $—  $9,232  
Corporate investments—  3,066  25,683  28,749  —  4,717  30,311  35,028  
Foreign-currency forward contracts (2)
—  3,295  —  3,295  —  —  —  —  
Total assets$8,611  $6,361  $25,683  $40,655  $9,232  $4,717  $30,311  $44,260  
Liabilities
Foreign-currency forward contracts (3)
$—  $—  $—  $—  $—  $(1,703) $—  $(1,703) 

(1) Carrying value approximates fair value due to the short-term nature.
(2) Amounts are included in other assets in the condensed consolidated statements of financial condition.
(3) Amounts are included in accounts payable, accrued expenses and other liabilities in the condensed consolidated statements of financial condition, except for $94 as of December 31, 2019, which is included within corporate investments in the condensed consolidated statements of financial condition.
Summary of Changes in Fair Value of Level III Investments
The table below sets forth a summary of changes in the fair value of Level III financial instruments:
Three months ended March 31,
20202019
Corporate InvestmentsContingent LiabilityCorporate InvestmentsContingent Liability
Beginning balance$30,311  $—  $45,426  $(6,657) 
Contributions or additions1,790  —  —  —  
Distributions(2,459) —  —  —  
Net gain (loss) included in earnings(3,959) —  2,997  81  
Ending balance$25,683  $—  $48,423  $(6,576) 
Net change in unrealized gains (losses) attributable to financial instruments still held at end of period
$(3,959) $—  $2,997  $81  
The table below sets forth a summary of the valuation techniques and quantitative information utilized in determining the fair value of the Company’s Level III financial instruments:
Fair Value as ofSignificant Unobservable Input
Financial InstrumentMarch 31, 2020December 31, 2019Valuation TechniqueRangeWeighted Average
Corporate investment – Limited partnership interests
$25,683  $30,311  Market approach
(value of underlying assets)
Not applicableNot applicableNot applicable
Summary of Changes in Fair Value of Level III Investments
The table below sets forth a summary of changes in the fair value of Level III financial instruments:
Three months ended March 31,
20202019
Corporate InvestmentsContingent LiabilityCorporate InvestmentsContingent Liability
Beginning balance$30,311  $—  $45,426  $(6,657) 
Contributions or additions1,790  —  —  —  
Distributions(2,459) —  —  —  
Net gain (loss) included in earnings(3,959) —  2,997  81  
Ending balance$25,683  $—  $48,423  $(6,576) 
Net change in unrealized gains (losses) attributable to financial instruments still held at end of period
$(3,959) $—  $2,997  $81  
The table below sets forth a summary of the valuation techniques and quantitative information utilized in determining the fair value of the Company’s Level III financial instruments:
Fair Value as ofSignificant Unobservable Input
Financial InstrumentMarch 31, 2020December 31, 2019Valuation TechniqueRangeWeighted Average
Corporate investment – Limited partnership interests
$25,683  $30,311  Market approach
(value of underlying assets)
Not applicableNot applicableNot applicable
The following tables set forth a summary of changes in the fair value of Level III investments:
Corporate Debt – Bank DebtCorporate Debt – All OtherEquities – Common StockEquities – Preferred StockReal EstateTotal
Three months ended March 31, 2020    
Beginning balance$77,736  $103,172  $130,437  $657  $230,741  $542,743  
Transfers into Level III
117,176  53,522  33  —  —  170,731  
Transfers out of Level III
(1,127) (12,093) —  —  —  (13,220) 
Purchases37,421  12,858  264,909  —  38,663  353,851  
Sales(174) (3,014) —  —  —  (3,188) 
Realized losses, net
(3) (58) —  —  —  (61) 
Unrealized depreciation, net
(31,234) (12,107) (31,148) (326) —  (74,815) 
Ending balance$199,795  $142,280  $364,231  $331  $269,404  $976,041  
Net change in unrealized appreciation (depreciation) attributable to assets still held at end of period
$(23,552) $(7,325) $(3,868) $(312) $9,941  $(25,116) 
Three months ended March 31, 2019               
Beginning balance$136,055  $185,378  $3,063  $1,426  $—  $325,922  
Transfers into Level III
17,510  8,754  5,410  —  —  31,674  
Transfers out of Level III
(33,820) (6,280) —  —  —  (40,100) 
Purchases7,097  17,158  —  —  —  24,255  
Sales(10,017) (6,801) (127) —  —  (16,945) 
Realized gains (losses), net
(9) (361) 26  —  —  (344) 
Unrealized appreciation (depreciation), net
(1,871) 3,353  (948) 56  —  590  
Ending balance$114,945  $201,201  $7,424  $1,482  $—  $325,052  
Net change in unrealized appreciation (depreciation) attributable to assets still held at end of period
$(3,758) $2,761  $(948) $56  $—  $(1,889) 
Valuation of Investments and Other Financial Instruments The table below summarizes the investments and other financial instruments of the consolidated funds by fair-value hierarchy level:
As of March 31, 2020As of December 31, 2019
Level ILevel IILevel IIITotalLevel ILevel IILevel IIITotal
Assets
Investments:
Corporate debt – bank debt
$—  $4,893,169  $199,795  $5,092,964  $—  $5,911,523  $149,642  $6,061,165  
Corporate debt – all other
—  881,413  142,280  1,023,693  —  903,246  31,266  934,512  
Equities – common stock
379  96  364,231  364,706  552  345  130,437  131,334  
Equities – preferred stock
—  331  331  —  —  657  657  
Real estate
—  3,048  269,404  272,452  —  —  230,741  230,741  
Total investments
379  5,777,726  976,041  6,754,146  552  6,815,114  542,743  7,358,409  
Derivatives:
Foreign-currency forward contracts
—  7,892  —  7,892  27  6,863  —  6,890  
Options and futures
—  726  —  726  —  —  —  —  
Total derivatives (1)
—  8,618  —  8,618  27  6,863  —  6,890  
Total assets$379  $5,786,344  $976,041  $6,762,764  $579  $6,821,977  $542,743  $7,365,299  
Liabilities
CLO debt obligations:
Senior secured notes
$—  $(5,126,069) $—  $(5,126,069) $—  $(5,613,846) $—  $(5,613,846) 
Subordinated notes
—  (104,536) —  (104,536) —  (154,153) —  (154,153) 
Total CLO debt obligations (2)
—  (5,230,605) —  (5,230,605) —  (5,767,999) —  (5,767,999) 
Derivatives:
Foreign-currency forward contracts
—  (27,353) —  (27,353) (202) (2,349) —  (2,551) 
Options and futures
(122) —  —  (122) —  —  —  —  
Total derivatives (3)
(122) (27,353) —  (27,475) (202) (2,349) —  (2,551) 
Total liabilities
$(122) $(5,257,958) $—  $(5,258,080) $(202) $(5,770,348) $—  $(5,770,550) 

(1) Amounts are included in other assets under “assets of consolidated funds” in the condensed consolidated statements of financial condition.
(2) The fair value of CLO liabilities is classified based on the more observable fair value of CLO assets. Please see notes 2 and 10 for more information.
(3) Amounts are included in accounts payable, accrued expenses and other liabilities under “liabilities of consolidated funds” in the condensed consolidated statements of financial condition
Summary of Valuation Techniques and Quantitative Information
The following table sets forth a summary of the valuation techniques and quantitative information utilized in determining the fair value of the consolidated funds’ Level III investments as of March 31, 2020:
Investment TypeFair ValueValuation Technique
Significant Unobservable
Inputs (1)(2)
Range
Weighted Average (3)
Credit-oriented investments:
  
Consumer discretionary:
$15,395  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Financials:
118,178  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Health care:
24,000  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Real estate:
56,043  
Recent market information (5)
Quoted pricesNot applicableNot applicable
78,835  
Recent transaction price (8)
Quoted pricesNot applicableNot applicable
Other:
49,624  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Equity investments:
99,630  
Discounted cash flow (4)
Discount rate
6% – 8%
7%
218,356  
Recent transaction price (8)
Quoted pricesNot applicableNot applicable
46,576  
Market approach
(comparable companies) (6)
Earnings multiple (7)
5x - 7x
6x
Real estate investments:
269,404  
Recent transaction price (8)
Quoted pricesNot applicableNot applicable
Total Level III
investments
$976,041  
The following table sets forth a summary of the valuation techniques and quantitative information utilized in determining the fair value of the consolidated funds’ Level III investments as of December 31, 2019:
Investment TypeFair ValueValuation Technique
Significant Unobservable
Inputs (1)(2)
Range
Weighted Average (3)
Credit-oriented investments:
  
Consumer discretionary:
$16,836  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Financials:
17,274  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Health care:
26,863  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Real estate:
16,755  
Recent market information (5)
Quoted pricesNot applicableNot applicable
71,906  
Recent transaction price (4)
Quoted pricesNot applicableNot applicable
Other:
31,274  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Equity investments:
130,341  
Discounted cash flow (4)
Discount rate
6% – 8%
7%
753  
Recent market information (5)
Quoted pricesNot applicableNot applicable
Real estate-oriented:
230,741  
Recent transaction price (5)
Quoted pricesNot applicableNot applicable
Total Level III
investments
$542,743  

(1) The discount rate is the significant unobservable input used in the fair-value measurement of performing credit-oriented investments in which the consolidated funds do not have a controlling interest in the underlying issuer, as well as certain equity investments and real estate loan portfolios. An increase (decrease) in the discount rate would result in a lower (higher) fair-value measurement.
(2) Multiple of either earnings or underlying assets is the significant unobservable input used in the market approach for the fair-value measurement of distressed credit-oriented investments, credit-oriented investments in which the consolidated funds have a controlling interest in the underlying issuer, equity investments and certain real estate-oriented investments. An increase (decrease) in the multiple would result in a higher (lower) fair-value measurement.
(3) The weighted average is based on the fair value of the investments included in the range.
(4) A discounted cash-flow method is generally used to value performing credit-oriented investments in which the consolidated funds do not have a controlling interest in the underlying issuer, as well as certain equity investments, real estate-oriented investments and real estate loan portfolios.
(5) Certain investments are valued using vendor prices or broker quotes for the subject or similar securities.  Generally, investments valued in this manner are classified as Level III because the quoted prices may be indicative in nature for securities that are in an inactive market, may be for similar securities, or may require adjustment for investment-specific factors or restrictions.
(6) A market approach is generally used to value distressed investments and investments in which the consolidated funds have a controlling interest in the underlying issuer.
(7) Earnings multiples are based on comparable public companies and transactions with comparable companies. The Company typically utilizes multiples of EBITDA; however, in certain cases the Company may use other earnings multiples believed to be most relevant to the investment. The Company typically applies the multiple to trailing twelve-months’ EBITDA. However, in certain cases other earnings measures, such as pro forma EBITDA, may be utilized if deemed to be more relevant.
(8) Certain investments are valued based on recent transactions, generally defined as investments purchased or sold within six months of the valuation date. The fair value may also be based on a pending transaction expected to close after the valuation date.